NeoCura provides an AI medical platform to improve the precision diagnosis and treatment of tumors.
NeoCura provides an AI platform to collect and analyze molecular biology data and clinical data, enabling physicians to make improve the diagnosis and treatment of cancer patients.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 21, 2021 | Series A | ¥500M | 2 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Shunxi Fund | — | Series A |
Jiayin Investment | — | Series A |